Reply to Willoughby
Clin Infect Dis
.
2023 Sep 18;77(6):931-932.
doi: 10.1093/cid/ciad295.
Authors
Stacy M Holzbauer
1
2
,
Caroline A Schrodt
3
4
,
Rajesh M Prabhu
5
,
Rebecca J Asch-Kendrick
6
,
Malia Ireland
1
,
Carrie Klumb
1
,
Melanie J Firestone
1
3
,
Gongping Liu
1
,
Katie Harry
1
,
Min Z Levine
7
,
Lillian A Orciari
4
,
Kimberly Wilkins
4
,
James A Ellison
4
,
Hui Zhao
4
,
Michael Niezgoda
4
,
Panayampalli S Satheshkumar
4
,
Brett W Petersen
4
,
Agam K Rao
4
,
W Robert Bell
8
,
Sara Forrest
5
,
Wangcai Gao
9
,
Richard Dasheiff
5
,
Kari Russell
5
,
Anthony Wiseman
5
,
R Ross Reichard
10
,
Kirk E Smith
1
,
Ruth Lynfield
1
,
Joni Scheftel
1
,
Ryan M Wallace
4
,
Jesse Bonwitt
4
Affiliations
1
Minnesota Department of Health, St. Paul, Minnesota, USA.
2
Career Epidemiology Field Officer Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
3
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
4
Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
5
Essentia Health, Duluth, Minnesota, USA.
6
Midwest Medical Examiner's Office, Ramsey, Minnesota, USA.
7
Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
8
University of Minnesota, Minneapolis, Minnesota, USA.
9
Allina Health, The Commons at Midtown Exchange, Minneapolis, Minnesota, USA.
10
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
PMID:
37200504
PMCID:
PMC11360946
DOI:
10.1093/cid/ciad295
No abstract available
Publication types
Letter
Comment
Grants and funding
CC999999/ImCDC/Intramural CDC HHS/United States